All terms in GO

Label Id Description
negative regulation of protein localization to phagocytic vesicle GO_1905170 [Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to phagocytic vesicle.]
relaxation of cardiac muscle GO_0055119 [The process in which the extent of cardiac muscle contraction is reduced.]
GO_0070752 GO_0070752
positive regulation of protein localization to phagocytic vesicle GO_1905171 [Any process that activates or increases the frequency, rate or extent of protein localization to phagocytic vesicle.]
interleukin-35 production GO_0070753 [The appearance of interleukin-35 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.]
regulation of interleukin-35 production GO_0070754 [Any process that modulates the frequency, rate, or extent of interleukin-35 production.]
negative regulation of cardiac muscle contraction GO_0055118 [Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle contraction.]
negative regulation of interleukin-35 production GO_0070755 [Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-35 production.]
regulation of vascular associated smooth muscle cell dedifferentiation GO_1905174 [Any process that modulates the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.]
positive regulation of interleukin-35 production GO_0070756 [Any process that activates or increases the frequency, rate, or extent of interleukin-35 production.]
negative regulation of vascular associated smooth muscle cell dedifferentiation GO_1905175 [Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.]
interleukin-35-mediated signaling pathway GO_0070757 [The series of molecular signals initiated by interleukin-35 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.]
RISC complex binding GO_1905172 [Binding to a RISC complex.]
eukaryotic translation initiation factor 2B complex assembly GO_1905173 [The aggregation, arrangement and bonding together of a set of components to form an eukaryotic translation initiation factor 2B complex.]
negative regulation of interleukin-35-mediated signaling pathway GO_0070759 [Any process that decreases the rate, frequency or extent of an interleukin-35-mediated signaling pathway.]
regulation of cardiac muscle tissue regeneration GO_1905178 [Any process that modulates the frequency, rate or extent of cardiac muscle tissue regeneration.]
negative regulation of cardiac muscle tissue regeneration GO_1905179 [Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle tissue regeneration.]
positive regulation of vascular associated smooth muscle cell dedifferentiation GO_1905176 [Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.]
otolith mineralization completed early in development GO_0031173 [The formation of otoliths during embryogenesis with completion in early postembryonic development. Formation occurs by precipitation of specific crystal forms of calcium carbonate around an organic core of extracellular matrix proteins. Otoconia (otoliths) are small (~10 micron) dense extracellular particles present in the otolith end organs of the vertebrate inner ear.]
otolith mineralization GO_0045299 [The precipitation of specific crystal forms of calcium carbonate with extracellular matrix proteins in the otolith organs of the vertebrate inner ear.]